My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
SU0006399 SSCRPT
EnvironmentalHealth
>
EHD Program Facility Records by Street Name
>
K
>
KILE
>
7500
>
2600 - Land Use Program
>
PA-0600679
>
SU0006399 SSCRPT
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
5/7/2020 11:32:22 AM
Creation date
9/6/2019 10:40:41 AM
Metadata
Fields
Template:
EHD - Public
ProgramCode
2600 - Land Use Program
FileName_PostFix
SSCRPT
RECORD_ID
SU0006399
PE
2622
FACILITY_NAME
PA-0600679
STREET_NUMBER
7500
Direction
W
STREET_NAME
KILE
STREET_TYPE
RD
City
LODI
APN
00118012 13
ENTERED_DATE
1/17/2007 12:00:00 AM
SITE_LOCATION
7500 W KILE RD
RECEIVED_DATE
1/16/2007 12:00:00 AM
P_LOCATION
99
P_DISTRICT
004
QC Status
Approved
Scanner
SJGOV\rtan
Supplemental fields
FilePath
\MIGRATIONS\K\KILE\7500\PA-0600679\SU0006399\SSC RPT.PDF
Tags
EHD - Public
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
60
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
EXTOXNET PIP -IMIDACLOPRID Page 2 of 4 <br /> mg/meters cubed air in the form of dust. These values represent the maximum attainable airborne concentrations <br /> M. <br /> • Signs and Symptoms of Poisoning: Although no account of human poisoning was found in the literature, signs <br /> and symptoms of poisoning would be expected to be similar to nicotinic signs and symptoms, including fatigue, <br /> twitching, cramps, and muscle weakness including the muscles necessary for breathing (330). <br /> • Chronic Toxicity: A 2-year feeding study in rats fed up to 1,800 ppm resulted in a No Observable Effect Level <br /> (NOEL) of 100 ppm(5.7 mg/kg body weight in males and 7.6 mg/kg in females). Adverse effects included <br /> decreased body weight gain in females at 300 ppm, and increased thyroid lesions in males at 300 ppm and females <br /> at 900 ppm. A 1-year feeding study in dogs fed up to 2,500 ppm resulted in a NOEL of 1,250 ppm(41 mg/kg). <br /> Adverse effects included increased cholesterol levels in the blood, and some stress to the liver(measured by <br /> elevated liver cytochrome p-450 levels) (331). <br /> • Reproductive Effects: A three generation reproduction study in rats fed up to 700 ppm imidacloprid resulted in a <br /> NOEL of 100 ppm(equivalent to 8 mg/kg/day)based on decreased pup body weight observed at the 250 ppm dose <br /> level (331). <br /> • Teratogenic Effects: A developmental toxicity study in rats given doses up to 100 ppm by gavage on days 6 to 16 <br /> of gestation resulted in a NOEL of 30 mg/kg/day (based on skeletal abnormalities observed at the next highest dose <br /> tested of 100 ppm) (329). In a developmental toxicity study with rabbits given doses of imidacloprid by gavage <br /> during days 6 through 19 of gestation, resulted in a NOEL of 24 mg/kg/day based on decreased body weight and <br /> skeletal abnormalities observed at 72 mg/kg/day (highest dose tested) (331). <br /> • Mutagenic Effects: Imidacloprid may be weakly mutagenic. In a battery of 23 laboratory mutagenicity assays, <br /> imidacloprid tested negative for mutagenic effects in all but two of the assays. It did test positive for causing <br /> changes in chromosomes in human lymphocytes, as well as testing positive for genotoxicity in Chinese hamster <br /> ovary cells (331). <br /> • Carcinogenic Effects: Imidacloprid is considered to be of minimal carcinogenic risk, and is thus categorized by <br /> EPA as a"Group E" carcinogen(evidence of noncarcinogenicity for humans). There were no carcinogenic effects <br /> in a 2-year carcinogenicity study in rats fed up to 1,800 ppm imidacloprid(328). <br /> • Organ Toxicity: In short-term feeding studies in rats, there were thyroid lesions associated with very high doses of <br /> imidacloprid(331). <br /> • Fate in Humans and Animals: Imidacloprid is quickly and almost completely absorbed from the gastrointestinal <br /> tract, and eliminated via urine and feces (70-80% and 20-30%, respectively, of the 96% of the parent compound <br /> administered within 48 hours). The most important metabolic steps include the degradation to 6-chloronicotinic <br /> acid, a compound that acts on the nervous system as described above. This compound may be conjugated with <br /> glycine and eliminated, or reduced to guanidine(1). <br /> ECOLOGICAL EFFECTS <br /> • Effects on Birds: Imidacloprid is toxic to upland game birds. The LD50 is 152 mg/kg for bobwhite quail, and 31 <br /> mg/kg in Japanese quail (223, 1). In studies with red-winged blackbirds and brown-headed cowbirds, it was <br /> observed that birds learned to avoid imidacloprid treated seeds after experiencing transitory gastrointestinal distress <br /> (retching) and ataxia(loss of coordination). It was concluded that the risk of dietary exposure to birds via treated <br /> seeds was minimal. Based on these studies, imidacloprid appears to have potential as a bird repellent seed treatment <br /> (332, 333). <br /> • Effects on Aquatic Organisms: The toxicity of imidacloprid to fish is moderately low. The 96-hour LC50 of <br /> imidacloprid is 211 mg/I for rainbow trout, 280 mg/1 for carp, and 237 mg/1 for golden orfe. In tests with the aquatic <br /> invertebrate Daphnia, the 48-hour EC50 (effective concentration to cause toxicity in 50%of the test organisms)was <br /> 85 mg/l (1). Products containing imidacloprid may be very toxic to aquatic invertebrates. <br /> • Effects on Other Animals (Nontarget species): Imidacloprid is highly toxic to bees if used as a foliar application, <br /> especially during flowering, but is not considered a hazard to bees when used as a seed treatment(1). <br /> ENVIRONMENTAL FATE <br /> http://extoxnet.orst.edu/pips/imidaclo.htm 12/20/2006 <br />
The URL can be used to link to this page
Your browser does not support the video tag.